Multicenter, retrospective/prospective;2019–2021;114 adults with FLT3-mutated AML;RIC with midostaurin 100% (n = 83 achieved CR, n = 31 did not achieved CR);79/83 patients received 160 consolidation courses and 12/31 patients received re-induction. This evidence concerns the gene FLT3 and acute myeloid leukemia.